Literature DB >> 11310271

[Confirmation of the high prevalence of attention deficit disorder in a Colombian community].

D A Pineda1, F Lopera, G C Henao, J D Palacio, F X Castellanos.   

Abstract

INTRODUCTION: Using a shortened rating scale, the prevalence of Attention Deficit Hyperactivity Disorder (ADHD) has been reported to be very higher in a Colombian population. However, these data require clinical confirmation.
OBJECTIVE: To confirm clinically the prevalence of ADHD in Colombian children and adolescents. PATIENTS AND METHODS: A randomized sample of 4 to 17 year old children and adolescents--184 males and 157 females--was selected from the schools. Sample was stratified in two socioeconomic status: high (4, 5, 6) and low (1, 2, 3). Several parents' and teachers' rating scales for the diagnosis of ADHD, standardized and validated in the Colombian population, were applied to the sample. The diagnosis of ADHD was confirmed using a semi-structured psychiatric and neurological interview, and medical histories revisions.
RESULTS: Analysis found that prevalence of ADHD is 17.1%. Distribution for ADHD types was: combined 9.4%, inattentive 6.7% and hyperactive-impulsive 1%. Prevalence for boys was significant higher (21.8%) than for girls (10.9%) (chi 2 = 11.8, p < 0.01). In male predominate combined type and in female inattentive. Higher prevalence was found in low socioeconomic strata. Preschool children have lower prevalence (6.2%) than school 6 to 11 year old children (22.6%) and adolescents (21.6%).
CONCLUSION: A higher prevalence of ADHD was confirmed in Colombian population.

Entities:  

Mesh:

Year:  2001        PMID: 11310271

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  8 in total

1.  The worldwide prevalence of ADHD: is it an American condition?

Authors:  Stephen V Faraone; Joseph Sergeant; Christopher Gillberg; Joseph Biederman
Journal:  World Psychiatry       Date:  2003-06       Impact factor: 49.548

2.  Estimated prevalence of attention-deficit/hyperactivity disorder in a sample of Panamanian school-aged children.

Authors:  Emelyn Y Sánchez; Silvia Velarde; Gabrielle B Britton
Journal:  Child Psychiatry Hum Dev       Date:  2011-04

3.  Prevalence of Attention-Deficit Hyperactivity Disorder in Students and Needs Modification of Mental Health Services in Shahrekord, Iran in 2013.

Authors:  Parvin Safavi; Forouzan Ganji; Atenasadat Bidad
Journal:  J Clin Diagn Res       Date:  2016-04-01

4.  Environmental influences that affect attention deficit/hyperactivity disorder: study of a genetic isolate.

Authors:  David A Pineda; Luis Guillermo Palacio; Isabel C Puerta; Vilma Merchán; Clara P Arango; Astrid Yuleth Galvis; Mónica Gómez; Daniel Camilo Aguirre; Francisco Lopera; Mauricio Arcos-Burgos
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-08       Impact factor: 4.785

5.  Prevalence of Attention-Deficit/Hyperactivity Disorder Symptoms in Preschool-aged Iranian Children.

Authors:  Alipasha Meysamie; Maryam Daneshvar Fard; Mohammad-Reza Mohammadi
Journal:  Iran J Pediatr       Date:  2011-12       Impact factor: 0.364

6.  Prevalence rates of attention deficit/hyperactivity disorder in a school sample of Venezuelan children.

Authors:  Cecilia Montiel; Joaquín A Peña; Isabel Montiel-Barbero; Guilherme Polanczyk
Journal:  Child Psychiatry Hum Dev       Date:  2007-12-22

7.  Prevalence of probable Attention-Deficit/Hyperactivity Disorder symptoms: result from a Spanish sample of children.

Authors:  Alberto José Cerrillo-Urbina; Antonio García-Hermoso; Vicente Martínez-Vizcaíno; María Jesús Pardo-Guijarro; Abel Ruiz-Hermosa; Mairena Sánchez-López
Journal:  BMC Pediatr       Date:  2018-03-15       Impact factor: 2.125

8.  Do Teachers Confirm Parent's Ratings of ADHD DSM-IV Criteria? A Study of a Mexican Population.

Authors:  Yaira Chamorro; Lourdes Bolaños; Salvador Trejo; Omar Barrios; María de Lourdes Ramírez-Dueñas; Pablo Alvarez-Tostado; Alan Cervantes; Esmeralda Matute
Journal:  Neuropsychiatr Dis Treat       Date:  2021-06-16       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.